Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3-day versus 5-day cotrimoxazole for non-severe childhood pneumonia
ACTRN12612000994886Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Jul 2001
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in pneumonia comparing 3-day cotrimoxazole then placebo with 5-day cotrimoxazole (2 arms). Primary endpoint: Treatment failure. Started Jul 2001; status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
pneumonia
Beyond the preview
Go deeper on ACTRN12612000994886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000994886.